Join
Live feed
·
PRReleasevia Quantisnow
Esperion Therapeutics Inc. logo
KKR & Co. Inc. logo

Esperion Therapeutics and Corstasis Therapeutics Announce Esperion's Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst™ (bumetanide nasal spray)

ByQuantisnow·Wall Street's wire, on your screen.
ESPR· Esperion Therapeutics Inc.KKR· KKR & Co. Inc.
Health CareFinance

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ESPR (Esperion Therapeutics Inc.), KKR (KKR & Co. Inc.) and more on Quantisnow.